Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,161
Closed -$1.16M 1006
2025
Q4
$1.16M Buy
+12,161
New +$1.23M 0.05% 285
2023
Q1
Sell
-500
Closed -$75.1K 748
2022
Q4
$75.1K Buy
+500
New +$76.9K ﹤0.01% 716
2022
Q3
Sell
-500
Closed -$75K 1062
2022
Q2
$75K Hold
500
﹤0.01% 914
2022
Q1
$85K Sell
500
-1,662
-77% -$279K ﹤0.01% 953
2021
Q4
$557K Buy
2,162
+61
+3% +$16.7K 0.02% 622
2021
Q3
$573K Buy
2,101
+818
+64% +$260K 0.02% 609
2021
Q2
$287K Buy
1,283
+183
+17% +$34.5K 0.01% 776
2021
Q1
$121K Buy
+1,100
New +$117K 0.01% 819
2020
Q4
Sell
-10,227
Closed -$708K 829
2020
Q3
$708K Buy
10,227
+3,426
+50% +$246K 0.03% 359
2020
Q2
$454K Buy
+6,801
New +$340K 0.03% 396

Other funds holding BNTX

CSS LLC's BNTX Position: Q1 2026 in Review

CSS LLC sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 12,161 shares — an estimated $1.16M sold.

CSS LLC first reported a position in BNTX in Q2 2020 and held it in 10 quarters. The position peaked at $1.16M in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • CSS LLC reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • CSS LLC sold 12,161 BioNTech shares in Q1 2026, an estimated $1.16M.
  • CSS LLC first reported a position in BioNTech in Q2 2020 and held it in 10 quarters.
  • CSS LLC's BioNTech position peaked at $1.16M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.